You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 1, July 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Experimental Use of Folinic Acid in the Treatment of Toxoplasmosis With Pyrimethamine

CONRAD L. GILES, MD; LEON JACOBS, PhD; MARJORIE L. MELTON, BS

Arch Ophthalmol. 1964;72(1):82-85.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Summers1 first reported that in treating acute murine toxoplasmosis the combination of folic acid administration with pyrimethamine (Daraprim) therapy did not reverse the antitoxoplasmal action of pyrimethamine and appeared to lessen its toxic action. Cook2 found that in mouse mince-tissue cultures folic acid antagonized the antitoxoplasmal activity of pyrimethamine when the vitamin was present in concentrations eight times that of the drug. In monkey kidney epithelial cell cultures, neither folic acid nor folinic acid had a discernible antagonistic effect on pyrimethamine when the vitamins were added to the culture medium at a concentration 24 times higher than the drug, ie, 12 mg/100 ml:0.5 mg/100 ml. When the drug concentration was reduced to 0.5 mg/ 100 ml, both folic and folinic acid allowed the survival of Toxoplasma gondii in the cells, although no cytopathic effects appeared in the cultures.

Frenkel and Hitchings3 and Eyles and Coleman4 . . . [Full Text PDF of this Article]


Author Affiliations

Detroit; Bethesda, Md

From the Ophthalmology Branch (Dr. Giles), National Institute of Neurological Diseases and Blindness, and from the Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Public Health Service, Department of Health, Education and Welfare.


Footnotes

Submitted for publication Jan 10, 1964.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.